Transaction Advisory Services

TRANSACTION ADVISORY SERVICES

Superior execution and growth

Transaction Advisory Services

Founded in 1981, First Analysis has built a lasting legacy of supporting both emerging and established B2B tech companies. We partner with entrepreneurs and their organizations to maximize value in transactions, drawing on our deep sector knowledge and relationships and our outstanding execution capabilities.

First Analysis emphasizes direct senior-level engagement in offering a broad array of transaction advisory services that can support growth-stage businesses across the life cycles of their journeys.

Growth capital

Growth capital raises: $20MM-$100MM for rapidly growing companies with clear use of proceeds to accelerate business.

Minority recapitalizations: Combination of growth capital and liquidity for our partners that need growth capital but aren’t willing to cede majority control to a third-party partner.

M&A

Strategic exit: Build thoughtful, creative engagements with potential strategic buyers or partners to position our clients to be bought, not sold.

Majority recapitalizations: Develop relationships with institutional financial firms to target the best partners for our clients when they want a second bite at the apple.

Select First Analysis transactions

Pharma IT
Mednet

Exclusive financial advisor

Mednet

Has been acquired by CRScube

Learn more
Pharma IT

Exclusive financial advisor

Mednet has been acquired by CRScube

$0,000,000

First Analysis acted as the exclusive financial advisor to Mednet, a leading provider of eClinical data management software, in its sale to CRScube. The transaction brings together two established eClinical technology providers whose complementary capabilities support the growing demand for flexible, integrated clinical research solutions across North America and Asia.

About Mednet

Mednet is a healthcare technology company with over 24 years of experience delivering eClinical solutions for the global life sciences community. Its EDC-centric platform improves the efficiency of studies of all types and sizes, while integrated tools support the design, build and management of clinical research. Mednet’s platform has been used by over 84,000 clinical site users, having supported more than 560,000 clinical trial participants.

www.mednetsolutions.com

About CRScube

CRScube is a global leader in eClinical solutions, dedicated to making clinical trials more accessible, efficient and impactful. As Korea’s number one eClinical vendor, its cutting-edge technology streamlines clinical data capture and analysis while ensuring compliance with regulatory requirements worldwide. CRScube’s cost-effective platform is trusted by over 1,000 clients and used in more than 6,000 trials.

www.crscube.io

Learn more
Healthcare ITInternet of things (IoT)
Intelligent Locations

Exclusive financial advisor

Intelligent Locations

Received growth investment from Marlin Equity Partners

Learn more
Healthcare ITInternet of things (IoT)

Exclusive financial advisor

Intelligent Locations received growth investment from Marlin Equity Partners

$0,000,000

First Analysis acted as the exclusive financial advisor to Intelligent Locations, a leading provider of AI-powered real-time location software for healthcare enterprises, in its growth investment from Marlin Equity Partners, a global investment firm specializing in the software, technology and services sectors.

About Intelligent Locations

Intelligent Locations pioneered the development of INTRAX™, delivering an advanced AI-powered localization platform for healthcare enterprises. Its software provides healthcare professionals with intuitive tools to track, measure and analyze assets, staff safety, patient satisfaction, operational workflows, environmental conditions and more. Headquartered in Raleigh’s Research Triangle, with a Center of Excellence in Paris, the company continuously advances its predictive analytics and machine learning capabilities.

intelligentlocations.io

About Marlin Equity Partners

Marlin Equity Partners is a global investment firm with nearly $10 billion in capital commitments specializing in the software, technology and services sectors. Marlin’s mission is to partner with exceptional management teams to drive scale and enhance long-term value in businesses through its deep domain expertise, extensive network and operational transformations focused on product innovation, go-to-market enhancements, and strategic M&A. Founded in 2005, Marlin has completed over 260 acquisitions. The firm is headquartered in Los Angeles, California, with an additional office in London.

marlinequity.com

Learn more
Healthcare IT
Upfront

Exclusive financial advisor

Upfront Healthcare

Has been acquired by Health Catalyst

Learn more
Healthcare IT

Exclusive financial advisor

Upfront Healthcare has been acquired by Health Catalyst

$0,000,000

First Analysis acted as the exclusive financial advisor to Upfront Healthcare Services (Upfront), a next-generation patient engagement platform provider, in its sale to Health Catalyst (Nasdaq: HCAT), a provider of data and analytics technology and services to healthcare organizations.

About Upfront Healthcare

Upfront is a mission-driven healthcare company delivering tangible outcomes to leading healthcare systems and provider groups. Its patient engagement and access platform makes each patient feel seen, guiding their care experience through personalized outreach. The backbone of the Upfront experience is its data engine, which analyzes clinical, sociodemographic, and patient-reported data. These insights, along with its advanced psychographic segmentation model, allow Upfront to individually activate patients to get the care they need while building a meaningful relationship between the patient and their health system. Upfront is rooted in partnership, leveraging best-in-class healthcare expertise to maximize the impact of technology and deliver a next-generation patient experience.

upfronthealthcare.com

About Health Catalyst

Health Catalyst (HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, financial, and operational improvement. More than 1,000 organizations worldwide rely on Health Catalyst’s offerings, including our cloud-based technology ecosystem Health Catalyst Ignite™, AI-enabled data and analytics solutions, and expert services to drive meaningful outcomes across hundreds of millions of patient records. Powered by high-value data, standardized measures and registries, and deep healthcare domain expertise, Ignite helps organizations transform complex information into actionable insights. Backed by a multi-decade mission and a proven track record of delivering billions of dollars in measurable results, Health Catalyst continues to serve as the catalyst for massive, measurable, data-informed healthcare improvement and innovation.

www.healthcatalyst.com

Learn more
Future of work
The Benefits Expert

Exclusive financial advisor

TBX

Has been acquired by Selerix

Learn more
Future of work

Exclusive financial advisor

TBX has been acquired by Selerix

$0,000,000

First Analysis acted as the exclusive financial advisor to The Benefits eXpert® (TBX), an employee benefits technology company that offers an engagement, education and administrative platform, in its sale to Selerix, a provider of cloud-based benefits administration and communications solutions.

About TBX

Headquartered in Plano, Texas, TBX is transforming the workplace benefits enrollment and administrative landscape through innovative self-service technology. Its mobile-responsive platform streamlines engagement, education and enrollment, empowering employees to make informed benefits decisions. TBX combines behavioral science-based educational videos, a data-driven decision support tool, and bilingual English–Spanish capabilities to deliver clarity and accessibility. Employers gain a no-cost enrollment solution implemented in 45 days or less, with proactive data audits, seamless electronic data exchange, call center support, and exceptional customer service – offering significant administrative and financial relief. TBX is a trusted partner for organizations seeking efficient and impactful benefits management.

tbxbenefits.com

About Selerix

Selerix is an industry-leading benefits administration provider for both core and voluntary benefits. Its solution combines a flexible benefits admin platform with a commitment to providing best-in-class client service. In addition, the Selerix platform includes ACA reporting and employee engagement to deliver a fully featured, all-in-one package. Trusted by brokers, carriers, over 25,000 employer groups, and 14 million individuals, the Selerix mission is to deliver benefits administration solutions that actually benefit employees. 

selerix.com

Learn more

Latest advisory news

Advisory Success Stories
Investment banking
Pharma IT
Mednet 2025

First Analysis acted as the exclusive financial advisor to Mednet in its sale to CRScube

First Analysis acted as the exclusive financial advisor to Mednet, a leading provider of eClinical data management software, in its sale to CRScube. The transaction brings together two established eClinical technology providers whose complementary capabilities support the growing demand for flexible, integrated clinical research solutions across North America and Asia.
Learn more: First Analysis acted as the exclusive financial advisor to Mednet in its sale to CRScube Load More : First Analysis acted as the exclusive financial advisor to Mednet in its sale to CRScube
Venture capitalInvestment banking
Healthcare ITInternet of things (IoT)
Intelligent Locations

First Analysis advised, invested in healthcare tech provider Intelligent Locations

First Analysis Securities Corp. advised Intelligent Locations on its recent growth investment from Marlin Equity Partners. Intelligent Locations is a leading provider of AI-powered real-time location software for healthcare enterprises. Intelligent Locations’ suite of solutions enables hospitals to track assets, people and processes in real-time. Venture capital fund First Analysis Fund XIV also participated in the investment. The investment will support further advancement of Intelligent Locations’ AI-powered INTRAXTM platform to optimize critical business and clinical operations for hospitals.
Learn more: First Analysis advised, invested in healthcare tech provider Intelligent Locations Load More : First Analysis advised, invested in healthcare tech provider Intelligent Locations
Investment banking
Healthcare IT
Tbx Tombstone 2025

First Analysis acted as the exclusive financial advisor to TBX® in its sale to Selerix

First Analysis acted as the exclusive financial advisor to The Benefits eXpert® (TBX®), an employee benefits technology company that offers an engagement, education and administrative platform, in its sale to Selerix, a provider of cloud-based benefits administration and communications solutions.
Learn more: First Analysis acted as the exclusive financial advisor to TBX® in its sale to Selerix Load More : First Analysis acted as the exclusive financial advisor to TBX® in its sale to Selerix
Investment banking
Healthcare IT
Upfront 2025

First Analysis acted as the exclusive financial advisor to Upfront Healthcare in its sale to Health Catalyst

First Analysis acted as the exclusive financial advisor to Upfront Healthcare Services (Upfront), a next-generation patient engagement platform provider, in its sale to Health Catalyst (Nasdaq: HCAT), a provider of data and analytics technology and services to healthcare organizations.
Learn more: First Analysis acted as the exclusive financial advisor to Upfront Healthcare in its sale to Health Catalyst Load More : First Analysis acted as the exclusive financial advisor to Upfront Healthcare in its sale to Health Catalyst
Investment banking
Healthcare IT
Pqs 2024 Gfx 21032024225415

First Analysis acted as the exclusive financial advisor to Pharmacy Quality Solutions in its sale to Innovaccer

First Analysis acted as the exclusive financial advisor to Pharmacy Quality Solutions (PQS), a leading pharmacy-payer performance technology, in its sale to Innovaccer. The terms of the transaction were not disclosed.
Learn more: First Analysis acted as the exclusive financial advisor to Pharmacy Quality Solutions in its sale to Innovaccer Load More : First Analysis acted as the exclusive financial advisor to Pharmacy Quality Solutions in its sale to Innovaccer

Investment banking and corporate finance services are provided through First Analysis Securities Corporation (“FASC” or “First Analysis Securities”), a subsidiary of First Analysis Corp.